CHU et al., 1993 - Google Patents
Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell linesCHU et al., 1993
View PDF- Document ID
- 12789987179509707298
- Author
- CHU T
- KAWINSKI E
- LIN T
- Publication year
- Publication venue
- Hybridoma
External Links
Snippet
Using viable adriamycin resistant human ovarian carcinoma cells 2780AD and colchicine resistant human oral epidermoid carcinoma cells KB-24 as the immunogen in primary and subsequent ip. immunizations, followed by iv. boostings with crude plasma membranes of …
- 210000004027 cells 0 title abstract description 122
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3353209B2 (en) | Antibodies to αvβ3 integrin | |
| Sabbaga et al. | A murine nephritogenic monoclonal anti‐DNA autoantibody binds directly to mouse laminin, the major non‐collagenous protein component of the glomerular basement membrane | |
| US4762706A (en) | Peptide antibodies and their use in detecting oncogene products | |
| EP0175360A2 (en) | Peptide antibodies and their use in detecting oncogene products | |
| JP2001503601A (en) | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen | |
| Wechsler-Reya et al. | The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells | |
| JPH09124697A (en) | Peptide and monoclonal antibody | |
| KR101363695B1 (en) | An antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved | |
| ES2214476T3 (en) | NEW MARKERS OF EVIL CELLULAR TYPES OF THE NUCLEAR MATRIX INTERIOR. | |
| CHU et al. | Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines | |
| US20100151486A1 (en) | Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof | |
| CA2624562A1 (en) | Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use | |
| Beckner et al. | Identification of a new immunoglobulin superfamily protein expressed in blood vessels with a heparin-binding consensus sequence | |
| EP0177814A2 (en) | Peptide antibodies and their use in detecting oncogene products | |
| Ono et al. | Monoclonal antibodies to restricted and cross‐reactive idiotopes on monoclonal rheumatoid factors and their recognition of idiotope‐positive cells | |
| CA2078373C (en) | Peptides for the production of preparations for the diagnosis and therapy of systemic lupus | |
| US5503984A (en) | Hybridoma producing monoclonal antibody F4 which specifically binds to multidrug resistant P-glycoprotein and assays for detection of P-glycoprotein | |
| US7629131B2 (en) | Rabbit monoclonal antibodies against mouse/human Id3 proteins | |
| US6306615B1 (en) | Detection method for monitoring β tubulin isotype specific modification | |
| JP2792651B2 (en) | Monoclonal antibodies against human pancreatic cancer | |
| ES2319386T3 (en) | HUMAN TYPE TRP CALCULATION CHANNEL PROTEIN 2 (TLCC-2). | |
| Zahra Adyel et al. | Characterization of autoantibody activities in sera anti‐DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients | |
| EP0190049B1 (en) | Method for selecting hybridomas producing antibodies specific to inaccessible cell surface antigens | |
| US7452676B2 (en) | Monoclonal antibodies to RNA binding protein GW182 | |
| Isojima | Sperm and seminal plasma antigens relevant to contraceptive vaccine development |